CRC
Colorectal cancer
Current focus
Initial case-control research identified an EV-associated signal in colorectal cancer, including early-stage disease. EVBiome is concentrating its development work in this indication.
Pipeline
Focused development in cancer detection
EVBiome is beginning with colorectal cancer while using research in non-small cell lung cancer to examine the broader relevance of its biological approach.
Areas of study
One focused indication. One supporting line of evidence.
The company's public pipeline is intentionally concise. CRC is the present focus; NSCLC provides an early opportunity to study whether EV-associated cancer signals extend beyond a single tumor type.
NSCLC
Non-small cell lung cancer
Supporting research
Initial research in early-stage NSCLC supports continued study of the biological approach beyond colorectal cancer.
All programs are research-stage. Information is qualitative and does not constitute a clinical performance claim.